{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T21:47:31Z","timestamp":1766267251082,"version":"3.40.5"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Association Francaise contre les Myopathies (AFM)","award":["14901","15816"],"award-info":[{"award-number":["14901","15816"]}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.yjmcc.2016.02.017","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T12:25:08Z","timestamp":1456575908000},"page":"84-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib"],"prefix":"10.1016","volume":"93","author":[{"given":"Valentina","family":"Sala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzo","family":"Medico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Vigna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Cantarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Fontani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Natale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Morello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Maria","family":"Comoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ponzetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3410-947X","authenticated-orcid":false,"given":"Tiziana","family":"Crepaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2016.02.017_bb0005","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","article-title":"Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.physiol.62.1.289","article-title":"Genetic dissection of cardiac growth control pathways","volume":"62","author":"MacLellan","year":"2000","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0015","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0020","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(98)00407-0","article-title":"Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death","volume":"32","author":"Haider","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2362.2010.02268.x","article-title":"Hypertrophic cardiomyopathy: from genetics to treatment","volume":"40","author":"Marian","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/hc2801.094031","article-title":"Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"104","author":"Patel","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0035","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2119\/molmed.2011.00512","article-title":"Signaling to cardiac hypertrophy: insights from human and mouse RASopathies","volume":"18","author":"Sala","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2009.02.075","article-title":"Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy","volume":"54","author":"Bos","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0045","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ajmg.a.33857","article-title":"Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras\/MAPK pathway syndrome","volume":"155a","author":"Lin","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-3-13","article-title":"Leopard syndrome","volume":"3","author":"Sarkozy","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0055","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/jmg.2006.042796","article-title":"The cardiofaciocutaneous syndrome","volume":"43","author":"Roberts","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.beem.2010.09.002","article-title":"Noonan syndrome and clinically related disorders","volume":"25","author":"Tartaglia","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0065","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrm3012","article-title":"MET signalling: principles and functions in development, organ regeneration and cancer","volume":"11","author":"Trusolino","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0070","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.onc.1210201","article-title":"From Tpr-Met to Met, tumorigenesis and tubes","volume":"26","author":"Peschard","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0075","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.CIR.95.11.2552","article-title":"Enhanced expression of hepatocyte growth factor\/c-Met by myocardial ischemia and reperfusion in a rat model","volume":"95","author":"Ono","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0008-6363(01)00272-3","article-title":"A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats","volume":"51","author":"Ueda","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0085","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00004872-199917090-00014","article-title":"Involvement of receptor-type tyrosine kinase gene families in cardiac hypertrophy","volume":"17","author":"Akiyama","year":"1999","journal-title":"J. Hypertens."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/HYPERTENSIONAHA.112.198986","article-title":"Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo","volume":"61","author":"Messaoudi","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0095","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jtcvs.2005.04.031","article-title":"Gene transfection of hepatocyte growth factor attenuates the progression of cardiac remodeling in the hypertrophied heart","volume":"130","author":"Iwata","year":"2005","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0100","doi-asserted-by":"crossref","first-page":"H2131","DOI":"10.1152\/ajpheart.01239.2003","article-title":"Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts","volume":"288","author":"Nakamura","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014675","article-title":"Activated Met signalling in the developing mouse heart leads to cardiac disease","volume":"6","author":"Leo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/bbrc.1996.0606","article-title":"Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction","volume":"221","author":"Matsumori","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0115","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.ijcard.2012.11.052","article-title":"A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure","volume":"168","author":"Richter","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0120","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/hrt.2010.220228","article-title":"Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure","volume":"97","author":"Rychli","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.155","article-title":"Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy","volume":"5","author":"Gallo","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0130","doi-asserted-by":"crossref","first-page":"H1155","DOI":"10.1152\/ajpheart.01323.2008","article-title":"Agonist monoclonal antibodies against HGF receptor protect cardiac muscle cells from apoptosis","volume":"298","author":"Pietronave","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0135","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00018-011-0633-6","article-title":"Novel therapy for myocardial infarction: can HGF\/Met be beneficial?","volume":"68","author":"Sala","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0140","first-page":"2204","article-title":"Met signaling in cardiomyocytes is required for normal cardiac function in adult mice","volume":"2013","author":"Arechederra","year":"1832","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0145","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0891-5849(01)00663-3","article-title":"Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis","volume":"31","author":"Kitta","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2014.12.021","article-title":"Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction","volume":"45","author":"Sonnenberg","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00395-010-0102-7","article-title":"Hepatocyte growth factor\/Met gene transfer in cardiac stem cells\u2014potential for cardiac repair","volume":"105","author":"Madonna","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0160","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3892\/ijmm.2014.1782","article-title":"Hepatocyte growth factor regulates the TGF-\u03b21-induced proliferation, differentiation and secretory function of cardiac fibroblasts","volume":"34","author":"Yi","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0092-8674(94)90318-2","article-title":"A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor\/scatter factor receptor family","volume":"77","author":"Ponzetto","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0170","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrc1912","article-title":"Invasive growth: a MET-driven genetic programme for cancer and stem cells","volume":"6","author":"Boccaccio","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0175","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1021\/jm401427c","article-title":"Targeting receptor tyrosine kinase MET in cancer: small molecule inhibitors and clinical progress","volume":"57","author":"Cui","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0180","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1128\/MCB.01580-07","article-title":"Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein","volume":"28","author":"Lei","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0185","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng.641","article-title":"Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia","volume":"42","author":"Niemeyer","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0190","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1590\/S0100-879X2012007500159","article-title":"Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy","volume":"45","author":"Chen","year":"2012","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0195","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1253\/circj.CJ-09-0465","article-title":"Global gene expression profiling in the failing myocardium","volume":"73","author":"Asakura","year":"2009","journal-title":"Circ. J."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0200","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.yjmcc.2006.12.016","article-title":"Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium","volume":"42","author":"Gabrielsen","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0205","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1074\/jbc.M610916200","article-title":"Conditional activation of MET in differentiated skeletal muscle induces atrophy","volume":"282","author":"Crepaldi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0210","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11248-012-9667-2","article-title":"Gene expression profiling of HGF\/Met activation in neonatal mouse heart","volume":"22","author":"Gatti","year":"2013","journal-title":"Transgenic Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0215","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1161\/CIRCULATIONAHA.112.130179","article-title":"Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases","volume":"127","author":"Vinchi","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0220","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nprot.2009.230","article-title":"Expander: from expression microarrays to networks and functions","volume":"5","author":"Ulitsky","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0225","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/gb-2007-8-1-r3","article-title":"GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists","volume":"8","author":"Carmona-Saez","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0230","doi-asserted-by":"crossref","first-page":"W317","DOI":"10.1093\/nar\/gkp416","article-title":"GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information","volume":"37","author":"Nogales-Cadenas","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0235","doi-asserted-by":"crossref","first-page":"W478","DOI":"10.1093\/nar\/gks402","article-title":"GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics","volume":"40","author":"Tabas-Madrid","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0240","doi-asserted-by":"crossref","first-page":"W316","DOI":"10.1093\/nar\/gkr483","article-title":"KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases","volume":"39","author":"Xie","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024289","article-title":"Functional analysis beyond enrichment: non-redundant reciprocal linkage of genes and biological terms","volume":"6","author":"Fontanillo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0250","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0255","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0260","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1093\/bioinformatics\/btq562","article-title":"GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop","volume":"26","author":"Montojo","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0265","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0270","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1093\/nar\/gki624","article-title":"oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes","volume":"33","author":"Ho Sui","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0275","doi-asserted-by":"crossref","first-page":"W245","DOI":"10.1093\/nar\/gkm427","article-title":"oPOSSUM: integrated tools for analysis of regulatory motif over-representation","volume":"35","author":"Ho Sui","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0280","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq149","article-title":"Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data","volume":"38","author":"Essaghir","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0285","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1158\/1078-0432.CCR-12-3459","article-title":"Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET","volume":"19","author":"Basilico","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0290","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.1016\/S0021-9258(19)81384-4","article-title":"Troponin T switching in the developing rat heart","volume":"263","author":"Saggin","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0295","doi-asserted-by":"crossref","first-page":"16299","DOI":"10.1016\/S0021-9258(18)71621-9","article-title":"Troponin I switching in the developing heart","volume":"264","author":"Saggin","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0300","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1242\/jcs.091140","article-title":"ERK1\/2 activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1","volume":"124","author":"Sbroggio","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cvr\/cvn133","article-title":"Remodelling of gap junctions and connexin expression in diseased myocardium","volume":"80","author":"Severs","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0310","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart: a new therapeutic target?","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0315","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0320","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1172\/JCI44929","article-title":"MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation","volume":"121","author":"Wu","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0325","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI44972","article-title":"Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation","volume":"121","author":"Marin","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0330","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno OF","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0335","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yjmcc.2008.09.002","article-title":"With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure","volume":"46","author":"Molkentin","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0340","doi-asserted-by":"crossref","first-page":"23173","DOI":"10.1074\/jbc.270.39.23173","article-title":"Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice","volume":"270","author":"Hunter","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0345","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yjmcc.2014.03.002","article-title":"Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction","volume":"72","author":"Ulm","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0350","doi-asserted-by":"crossref","first-page":"31246","DOI":"10.1074\/jbc.M806085200","article-title":"DUSP6 (MKP3) null mice show enhanced ERK1\/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility","volume":"283","author":"Maillet","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0355","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1073\/pnas.0610906104","article-title":"Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo","volume":"104","author":"Purcell","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0360","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1755-5922.2010.00152.x","article-title":"Cardiac natriuretic peptides: from basic discovery to clinical practice","volume":"29","author":"Hayek","year":"2011","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0365","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmcc.2001.1348","article-title":"MEK1\/2-ERK1\/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes","volume":"33","author":"Xiao","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0370","doi-asserted-by":"crossref","first-page":"H1242","DOI":"10.1152\/ajpheart.00451.2010","article-title":"Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK\/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation","volume":"299","author":"Reddy","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0375","doi-asserted-by":"crossref","first-page":"H796","DOI":"10.1152\/ajpheart.2000.278.3.H796","article-title":"Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice","volume":"278","author":"Saadane","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0380","first-page":"1025","volume":"62","author":"Sato","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0385","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-8278(01)00265-3","article-title":"Oncostatin M stimulates tissue inhibitor of metalloproteinase-1 via a MEK-sensitive mechanism in human myofibroblasts","volume":"36","author":"Sohara","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0390","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1160\/TH08-05-0294","article-title":"Transcriptional regulation of the plasminogen activator inhibitor type 1\u2014with an emphasis on negative regulation","volume":"100","author":"Nagamine","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0395","doi-asserted-by":"crossref","first-page":"L1281","DOI":"10.1152\/ajplung.00128.2007","article-title":"Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter","volume":"293","author":"Vayalil","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0400","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevEukarGeneExpr.v7.i1-2.90","article-title":"Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases","volume":"7","author":"Borden","year":"1997","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0405","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.critrevonc.2003.09.008","article-title":"TIMPs as multifacial proteins","volume":"49","author":"Lambert","year":"2004","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0410","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000369712","article-title":"Gene expression profile in the early stage of angiotensin II-induced cardiac remodeling: a time series microarray study in a mouse model","volume":"35","author":"Dang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0415","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/CIRCULATIONAHA.110.955245","article-title":"Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition","volume":"122","author":"Ghosh","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0420","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0425","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/CIRCHEARTFAILURE.113.000539","article-title":"Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model","volume":"6","author":"Hamdani","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0430","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","article-title":"Myocardial structure and function differ in systolic and diastolic heart failure","volume":"113","author":"van Heerebeek","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0435","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1067\/mhj.2001.112238","article-title":"Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome","volume":"141","author":"Inokubo","year":"2001","journal-title":"Am. Heart J."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0440","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/HJH.0b013e3283614c1c","article-title":"Circulating biomarkers of collagen metabolism in arterial hypertension: relevance of target organ damage","volume":"31","author":"Morillas","year":"2013","journal-title":"J. Hypertens."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0445","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.105.573865","article-title":"Matrix metalloproteinases\/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease","volume":"113","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0450","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coph.2005.01.007","article-title":"Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease","volume":"5","author":"De Taeye","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0455","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/eurjhf\/hft106","article-title":"Biomarkers of heart failure with normal ejection fraction: a systematic review","volume":"15","author":"Cheng","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0460","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1291\/hypres.22.161","article-title":"Hepatocyte growth factor (HGF) as a potential index of severity of hypertension","volume":"22","author":"Morishita","year":"1999","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0465","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/bbrc.1997.7800","article-title":"A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension","volume":"242","author":"Nakamura","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0470","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2141.2010.08127.x","article-title":"Blockade of the MEK\/ERK signalling cascade by AS703026, a novel selective MEK1\/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo","volume":"149","author":"Kim","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0475","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.18632\/oncotarget.659","article-title":"Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance","volume":"3","author":"McCubrey","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.yjmcc.2016.02.017_bb0480","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1749-8090-9-81","article-title":"Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf\/ERK1\/2 signaling pathway","volume":"9","author":"Daryadel","year":"2014","journal-title":"J. Cardiothorac. Surg."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228281630044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228281630044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T14:46:05Z","timestamp":1654440365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002228281630044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":96,"alternative-id":["S002228281630044X"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2016.02.017","relation":{},"ISSN":["0022-2828"],"issn-type":[{"type":"print","value":"0022-2828"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2016.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}